Contraception Comparison Chart Page 2
ADVERTISEMENT
1
2
3May
p erforate
u terus
o n
•
Continuous
c ontraceptive
insertion
(
EXTREMELY
R ARE)
•
protection
f or
u p
t o
5
/
3
y ears
May
b e
e xpelled
(
RARE)
•
Mirena
/
S kyla
Decreases
n umber
o f
b leeding
May
c ause
i rregular
b leeding
i n
•
•
days
p er
m onth
99.7%
the
f irst
3
m onths
o f
u se
(intrauterine
Non
h ormonal
RARE
h ormonal
s ide
e ffects
•
•
device
I UD)
Nothing
“ to
d o”
a fter
i n
o ffice
Increased
i nfection
r isk
i n
•
•
insertion
b y
p hysician
some
w omen
INSERTED NON HORMONAL DEVICE
May
p erforate
u terus
o n
•
insertion
(
EXTREMELY
R ARE)
May
b e
e xpelled
(
RARE)
•
Continuous
c ontraceptive
•
Paragard
Does
n ot
c ontrol
m enstrual
•
protection
f or
u p
t o
1 0
y ears
cycles
Non-‐hormonal
99.7
%
•
(intrauterine
Increased
i nfection
r isk
i n
•
Nothing
“ to
d o”
a fter
i n
o ffice
•
Device
I UD)
some
w omen
insertion
b y
p hysician
May
h ave
h eavier
o r
i rregular
•
bleeding
Comfort
l evel
w ith
i nsertion
•
Diaphragm
Reapplication
o f
s permicide
f or
•
Barrier
m ethod
I nsertion
u p
t o
•
repeated
i ntercourse
6
h ours
b efore
i ntercourse
82-‐94%
(with
Increased
r isk
o f
b ladder
•
Non
h ormonal
•
spermicide)
infections
Can
b e
m essy
f or
p artner
•
PERMANENT SURGICAL
Permanent
•
Risk
o f
r egret
i n
t he
f uture
•
Essure
Continuous
c ontraceptive
•
Requires
3
m onths
o f
•
protection
99.7%
alternative
b irth
c ontrol
u ntil
( tubal
Non-‐hormonal
•
tubes
c losed
a nd
No
i ncisions
r equired
occlusion)
•
closure
e valuated
a nd
•
confirmed
b y
x -‐ray
Permanent
S urgical
P rocedure
•
Continuous
c ontraceptive
•
(Minimally
I nvasive)
Tubal
L igation
protection
99.7%
(female)
Risk
o f
r egret
i n
t he
f uture
•
Non-‐
h ormonal
•
RARE
s urgical
c omplication
•
Continuous
c ontraceptive
•
Vasectomy
Permanent
S urgical
P rocedure
protection
•
99.7%
(male)
Non-‐hormonal
•
Provided
b y
m ale
p artner
•
ADVERTISEMENT
0 votes
Related Articles
Related forms
Related Categories
Parent category: Medical